Sagefield Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Sagefield Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,400	Closed	-$540K	–	112
2023 Q1	$540K	Buy	+22,400	New	+$281K	0.12%	79

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Sagefield Capital's PRVB Position: Q2 2023 in Review

Sagefield Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 22,400 shares — an estimated $540K sold.

Sagefield Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $540K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Sagefield Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Sagefield Capital sold 22,400 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $540K.
Sagefield Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Sagefield Capital's Provention Bio, Inc. Common Stock position peaked at $540K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Sagefield Capital's 13F filing for Q2 2023, filed 14 Aug 2023.